Globus Medical, Inc. (GMED) Stock Analysis & Investment Frameworks
Globus Medical, Inc. (GMED) stock analysis on Invetso. Review Globus Medical, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Globus Medical, Inc. Company Overview
- Exchange: New York Stock Exchange
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
Globus Medical, Inc. Key Financial Metrics
- Market Cap: $11.01B
- Revenue: $2.94B
- P/E Ratio: 20.45
- ROE: 11.59%
- ROIC: 10.46%
- Dividend Yield: N/A
About Globus Medical, Inc.
Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
Globus Medical, Inc. Investment Frameworks
Invetso analyzes Globus Medical, Inc. (GMED) across the following frameworks:
- Globus Medical, Inc. 10Y Growth Potential
- Globus Medical, Inc. Scenario Analysis
- Globus Medical, Inc. Risks & Opportunities
- Globus Medical, Inc. Economic Moat
- Globus Medical, Inc. Business Model
- Globus Medical, Inc. Management
- Globus Medical, Inc. SWOT Analysis
- Globus Medical, Inc. Porter's 5 Forces
- Globus Medical, Inc. PESTLE Analysis
- Globus Medical, Inc. ESG Analysis